Research graph
References from Trends in Cyst Size of Resected Intraductal Papillary Mucinous Neoplasms Over Time—Has the Evolution of the International Association of Pancreatology (IAP) Guidelines Impacted Surgical Thresholds. Local targets link to admitted publications; unresolved targets remain external evidence.
The Landmark Series: Intraductal Papillary Mucinous Neoplasms of the Pancreas—From Prevalence to Early Cancer Detection
10.1245/s10434-022-12870-w · 2023 · External reference
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms
10.1016/s2468-1253(22)00235-7 · 2022 · External reference
Pathways of Progression From Intraductal Papillary Mucinous Neoplasm to Pancreatic Ductal Adenocarcinoma Based on Molecular Features
10.1053/j.gastro.2018.10.029 · 2019 · External reference
Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas
10.1016/j.pan.2017.07.007 · 2017 · External reference
International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas
10.1016/j.pan.2012.04.004 · 2012 · External reference
Can we better predict the biologic behavior of incidental IPMN? A comprehensive analysis of molecular diagnostics and biomarkers in intraductal papillary mucinous neoplasms of the pancreas
10.1007/s00423-017-1644-z · 2018 · External reference
Pancreas Cyst Diagnosis and Advances in Cyst Fluid Analysis
10.1016/j.suc.2024.03.003 · 2024 · External reference
Incident Cases Captured in the National Cancer Database Compared with Those in U.S. Population Based Central Cancer Registries in 2012-2014
10.1245/s10434-019-07213-1 · 2019 · External reference
International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas
10.1159/000090023 · 2006 · External reference
European evidence-based guidelines on pancreatic cystic neoplasms
10.1136/gutjnl-2018-316027 · 2018 · External reference
International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas
10.1016/j.pan.2023.12.009 · 2024 · External reference
Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules
10.1097/mpa.0b013e3181bab60e · 2010 · External reference
International consensus on the management of intraductal papillary mucinous neoplasm of the pancreas
2015 · External reference
Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential
10.1016/j.jamcollsurg.2019.02.040 · 2019 · External reference
A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising From Pancreatic Cysts
10.1097/sla.0000000000005904 · 2023 · External reference
Predictive ability of pancreatic cyst fluid biomarkers: A systematic review and meta-analysis
10.1016/j.pan.2023.05.005 · 2023 · External reference
